TRACON Pharmaceuticals Inc (TCON) Insider Trading
- $26,368,737.18
- $4,169,336.23
- April 26, 2023
- Charles Theuer
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 26, 2023 | CEO | 3,999 | $0.66 | Buy | $2,639.34 | |
March 9, 2023 | Major Shareholder | 174,508 | $1.38 | Buy | $240,821.04 | |
Feb. 28, 2023 | CEO | 200 | $1.52 | Buy | $304.00 | |
Jan. 18, 2023 | CEO | 6,800 | $1.62 | Buy | $11,016.00 | |
Dec. 14, 2022 | CEO | 23,000 | $1.29 | Buy | $29,670.00 | |
Dec. 14, 2022 | Major Shareholder | 167,500 | $1.25 | Buy | $209,375.00 | |
Dec. 6, 2022 | Major Shareholder | 1,539 | $1.44 | Sell | $2,216.16 | |
Nov. 18, 2022 | CEO | 13,900 | $1.41 | Buy | $19,599.00 | |
Nov. 2, 2022 | CEO | 6,000 | $1.59 | Buy | $9,540.00 | |
Oct. 18, 2022 | Major Shareholder | 12,500 | $1.65 | Buy | $20,625.00 | |
Oct. 7, 2022 | CEO | 5,000 | $1.77 | Buy | $8,850.00 | |
Oct. 3, 2022 | CEO | 5,000 | $1.67 | Buy | $8,350.00 | |
Sept. 29, 2022 | Major Shareholder | 9,400 | $1.74 | Buy | $16,356.00 | |
Sept. 27, 2022 | Major Shareholder | 1,700 | $1.69 | Buy | $2,873.00 | |
Sept. 22, 2022 | Major Shareholder | 17,311 | $1.73 | Buy | $29,948.03 | |
Sept. 22, 2022 | CEO | 5,000 | $1.76 | Buy | $8,800.00 | |
Sept. 19, 2022 | Major Shareholder | 5,000 | $1.87 | Buy | $9,350.00 | |
Sept. 12, 2022 | CFO | 2,500 | $2.02 | Buy | $5,050.00 | |
July 26, 2022 | Major Shareholder | 2,254 | $1.72 | Buy | $3,876.88 | |
July 22, 2022 | CEO | 4,500 | $1.85 | Buy | $8,325.00 | |
July 15, 2022 | N/A | 11,826 | $1.78 | Buy | $21,050.28 | |
July 14, 2022 | Major Shareholder | 7,187 | $1.81 | Buy | $13,008.47 | |
July 13, 2022 | President and CEO | 3,000 | $1.84 | Buy | $5,520.00 | |
July 12, 2022 | President and CEO | 3,000 | $1.87 | Buy | $5,610.00 | |
June 24, 2022 | Major Shareholder | 11,419 | $1.39 | Buy | $15,872.41 | |
June 21, 2022 | Major Shareholder | 841,989 | $1.31 | Buy | $1,103,005.59 | |
May 10, 2022 | Major Shareholder | 9,700 | $1.76 | Buy | $17,072.00 | |
May 9, 2022 | CEO | 10,000 | $1.85 | Buy | $18,500.00 | |
May 6, 2022 | CEO | 2,500 | $1.97 | Buy | $4,925.00 | |
April 29, 2022 | CEO | 5,000 | $1.97 | Buy | $9,850.00 | |
April 25, 2022 | Major Shareholder | 10,777 | $2.18 | Buy | $23,493.86 | |
April 22, 2022 | Major Shareholder | 42,000 | $2.24 | Buy | $94,080.00 | |
April 21, 2022 | CEO | 4,500 | $2.30 | Buy | $10,350.00 | |
April 13, 2022 | Major Shareholder | 7,345 | $2.50 | Buy | $18,362.50 | |
April 11, 2022 | Major Shareholder | 9,100 | $2.42 | Buy | $22,022.00 | |
April 8, 2022 | CEO | 2,000 | $2.50 | Buy | $5,000.00 | |
March 30, 2022 | CEO | 4,000 | $2.70 | Buy | $10,800.00 | |
March 29, 2022 | CFO | 1,000 | $2.82 | Buy | $2,820.00 | |
March 21, 2022 | CEO | 1,200 | $2.45 | Buy | $2,940.00 | |
Jan. 28, 2022 | Major Shareholder | 500 | $2.20 | Buy | $1,100.00 | |
Jan. 24, 2022 | Major Shareholder | 17,363 | $2.05 | Buy | $35,594.15 | |
Jan. 21, 2022 | Major Shareholder | 35,000 | $2.19 | Buy | $76,650.00 | |
Jan. 19, 2022 | Major Shareholder | 23,688 | $2.24 | Buy | $53,061.12 | |
Dec. 29, 2021 | Major Shareholder | 52,325 | $2.51 | Buy | $131,335.75 | |
Dec. 27, 2021 | Major Shareholder | 87,325 | $2.92 | Buy | $254,989.00 | |
Dec. 15, 2021 | Major Shareholder | 21,964 | $2.43 | Buy | $53,372.52 | |
Dec. 13, 2021 | Major Shareholder | 15,204 | $2.64 | Buy | $40,138.56 | |
Dec. 6, 2021 | Major Shareholder | 22,733 | $2.26 | Buy | $51,376.58 | |
Dec. 3, 2021 | Major Shareholder | 89,274 | $2.30 | Buy | $205,330.20 | |
Nov. 18, 2021 | CEO | 681 | $2.88 | Buy | $1,961.28 |
Insiders are both buying and selling TRACON Pharmaceuticals Inc stock.
The insider traders at TRACON Pharmaceuticals Inc are: Opaleye Management Inc., Charles Theuer, Jafco Super V3 Investment Limi, Saundra L Pelletier, Mark C. Wiggins, Scott B Brown, THEUER CHARLES, Ikarian Capital, Llc, Scott B. Brown, William R Larue, Cross-Border Opportu Puissance, Enterprise Associates 14 New, H Casey Logan, Mark C Wiggins, M James Barrett, Peter W Sonsini, and Ronald L Shazer
The most active insider trader at TRACON Pharmaceuticals Inc is Opaleye Management Inc. with 36 trades.
Jafco Super V3 Investment Limi has sold the most TRACON Pharmaceuticals Inc stock with a total value of $3,865,450.63.
Ikarian Capital, Llc has bought the most TRACON Pharmaceuticals Inc stock with a total value of $10,307,322.95.
The most recent insider trade for TRACON Pharmaceuticals Inc was on April 26, 2023.
The single biggest insider buy for TRACON Pharmaceuticals Inc was from M James Barrett with a total value of $5,000,000.00 on Feb. 4, 2015.
The single biggest insider sell for TRACON Pharmaceuticals Inc was from Jafco Super V3 Investment Limi with a total value of $707,247.64 on Sept. 14, 2015.